Cargando…
How Proteins Bind Macrocycles
The potential utility of synthetic macrocycles as drugs, particularly against low druggability targets such as protein-protein interactions, has been widely discussed. There is little information, however, to guide the design of macrocycles for good target protein-binding activity or bioavailability...
Autores principales: | Villar, Elizabeth A., Beglov, Dmitri, Chennamadhavuni, Spandan, Porco, John A., Kozakov, Dima, Vajda, Sandor, Whitty, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417626/ https://www.ncbi.nlm.nih.gov/pubmed/25038790 http://dx.doi.org/10.1038/nchembio.1584 |
Ejemplares similares
-
Docking
Server for the Identification of Heparin Binding
Sites on Proteins
por: Mottarella, Scott E., et al.
Publicado: (2014) -
Cryptic binding sites on proteins: definition, detection, and druggability
por: Vajda, Sandor, et al.
Publicado: (2018) -
Fragments and hot spots in drug discovery
por: Vajda, Sandor, et al.
Publicado: (2015) -
FTMAP: extended protein mapping with user-selected probe molecules
por: Ngan, Chi Ho, et al.
Publicado: (2012) -
Evidence of Conformational Selection Driving the Formation of Ligand Binding Sites in Protein-Protein Interfaces
por: Bohnuud, Tanggis, et al.
Publicado: (2014)